Details
Stereochemistry | ACHIRAL |
Molecular Formula | C4H8O6S4.2Na |
Molecular Weight | 326.342 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[Na+].[Na+].[O-]S(=O)(=O)CCSSCCS([O-])(=O)=O
InChI
InChIKey=KQYGMURBTJPBPQ-UHFFFAOYSA-L
InChI=1S/C4H10O6S4.2Na/c5-13(6,7)3-1-11-12-2-4-14(8,9)10;;/h1-4H2,(H,5,6,7)(H,8,9,10);;/q;2*+1/p-2
Molecular Formula | C4H8O6S4 |
Molecular Weight | 280.363 |
Charge | -2 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | Na |
Molecular Weight | 22.9898 |
Charge | 1 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Dimesna is a prodrug of mesna (dimer of mesna). Dimesna is reduced to mesna in the kidneys. Dimesna does not prevent cellular damage by metabolites of ifosfamide and cyclophosphamide in the renal tubular cell line LLC-PK1. Dimesna is a mucolytic agent used to alleviate toxic side effects of antitumor drugs. The organic acid transporter OAT4 on the luminal side of the proximal renal tubule facilitates the reabsorption of dimesna, and therefore its reduction to mesna, whereas the multidrug and toxin extrusion protein MATE1, the multidrug resistance protein MRP2, and P glycoprotein facilitate the efflux of mesna and/or dimesna back into the lumen; dimesna may also be excreted unchanged by MRP4. It has therefore been suggested that polymorphism of these renal transport proteins or transporter-mediated drug-drug interactions may reduce the efficacy of mesna and dimesna.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: GO:0046785 Sources: https://www.ncbi.nlm.nih.gov/pubmed/20807779 |
PubMed
Title | Date | PubMed |
---|---|---|
[Prevention of urotoxic actions of cyclophosphamide and ifosfamide by dimesna (preliminary communication) (author's transl)]. | 1982 |
|
Prevention of cyclophosphamide-induced carcinogenesis in the urinary bladder of rats by administration of mesna. | 1983 Sep |
|
The chemical reactivity of BNP7787 and its metabolite mesna with the cytostatic agent cisplatin: comparison with the nucleophiles thiosulfate, DDTC, glutathione and its disulfide GSSG. | 2003 Jun |
|
Simultaneous determination of BNP7787 and its metabolite mesna in plasma and tissue by micro-HPLC with a dual electrochemical detector. | 2003 May |
|
The effect of cytoprotective agents in platinum anticancer therapy. | 2004 |
|
Pharmacokinetic behaviour of the chemoprotectants BNP7787 and mesna after an i.v. bolus injection in rats. | 2004 Apr 19 |
|
BNP7787-mediated modulation of paclitaxel- and cisplatin-induced aberrant microtubule protein polymerization in vitro. | 2010 Sep |
Patents
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:26:51 GMT 2023
by
admin
on
Fri Dec 15 15:26:51 GMT 2023
|
Record UNII |
230R951Y4D
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C2082
Created by
admin on Fri Dec 15 15:26:51 GMT 2023 , Edited by admin on Fri Dec 15 15:26:51 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
SUB07166MIG
Created by
admin on Fri Dec 15 15:26:51 GMT 2023 , Edited by admin on Fri Dec 15 15:26:51 GMT 2023
|
PRIMARY | |||
|
230R951Y4D
Created by
admin on Fri Dec 15 15:26:51 GMT 2023 , Edited by admin on Fri Dec 15 15:26:51 GMT 2023
|
PRIMARY | |||
|
716976
Created by
admin on Fri Dec 15 15:26:51 GMT 2023 , Edited by admin on Fri Dec 15 15:26:51 GMT 2023
|
PRIMARY | |||
|
16208-51-8
Created by
admin on Fri Dec 15 15:26:51 GMT 2023 , Edited by admin on Fri Dec 15 15:26:51 GMT 2023
|
PRIMARY | |||
|
CHEMBL2009034
Created by
admin on Fri Dec 15 15:26:51 GMT 2023 , Edited by admin on Fri Dec 15 15:26:51 GMT 2023
|
PRIMARY | |||
|
100000082639
Created by
admin on Fri Dec 15 15:26:51 GMT 2023 , Edited by admin on Fri Dec 15 15:26:51 GMT 2023
|
PRIMARY | |||
|
NN-30
Created by
admin on Fri Dec 15 15:26:51 GMT 2023 , Edited by admin on Fri Dec 15 15:26:51 GMT 2023
|
PRIMARY | |||
|
C027032
Created by
admin on Fri Dec 15 15:26:51 GMT 2023 , Edited by admin on Fri Dec 15 15:26:51 GMT 2023
|
PRIMARY | |||
|
760345
Created by
admin on Fri Dec 15 15:26:51 GMT 2023 , Edited by admin on Fri Dec 15 15:26:51 GMT 2023
|
PRIMARY | |||
|
m4503
Created by
admin on Fri Dec 15 15:26:51 GMT 2023 , Edited by admin on Fri Dec 15 15:26:51 GMT 2023
|
PRIMARY | Merck Index | ||
|
C1365
Created by
admin on Fri Dec 15 15:26:51 GMT 2023 , Edited by admin on Fri Dec 15 15:26:51 GMT 2023
|
PRIMARY | |||
|
240-337-2
Created by
admin on Fri Dec 15 15:26:51 GMT 2023 , Edited by admin on Fri Dec 15 15:26:51 GMT 2023
|
PRIMARY | |||
|
4888
Created by
admin on Fri Dec 15 15:26:51 GMT 2023 , Edited by admin on Fri Dec 15 15:26:51 GMT 2023
|
PRIMARY | |||
|
DTXSID6066024
Created by
admin on Fri Dec 15 15:26:51 GMT 2023 , Edited by admin on Fri Dec 15 15:26:51 GMT 2023
|
PRIMARY | |||
|
65625
Created by
admin on Fri Dec 15 15:26:51 GMT 2023 , Edited by admin on Fri Dec 15 15:26:51 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE |
|